dg health allergy relief
NDC 55910-594, loratadine, tablet, orally disintegrating, from Dolgencorp, LLC.
- Product NDC
- 55910-594
- Status
- Listed
- Labeler
- Dolgencorp, LLC
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA076011
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/55910-594 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LORATADINE10 mg/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 55910-594-46 | 55910059446 | 10 BLISTER PACK in 1 CARTON (55910-594-46) / 1 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK |
| 55910-594-65 | 55910059465 | 30 BLISTER PACK in 1 CARTON (55910-594-65) / 1 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 55910-594 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/55910-594 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 55910-594. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.